Research articlePublished 11 Aug 2016
Clinical Evaluation of Mucin-1 (MUC1) and P16 in Laryngeal Cancer
1Department of Obstetrics and Gynecology – Klinikum Innenstadt, Germany; 2Department of Otorhinolaryngology and Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Germany; 3Department of Pathology, LMU, Germany; 4Division of Clinical Pharmacology, LMU, Germany; 5Department of Legal Medicine, FAU, Germany; 6Department of Orthopedics, TUM, Germany; 7Glycotope, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Adapted from results in the field of cervical cancer, a direct connection between HPV infection and oropharyngeal carcinoma development could be established. Aim of this study was to evaluate p16 and TA-MUC1 in laryngeal cancer and their correlation to diagnostic, since TA-MUC1 is primarily restricted to malignancies. Methods: Paraffin-embedded laryngeal cancer specimens (n=129) and normal tissue (n=5) were analyzed for TA-MUC1 expression using hPankoMab-GEXTM antibody and evaluated according the immunoreactive score. Survival was assessed via log-rank test and Kaplan-Meier-survival analysis. Results: Significant correlation with tumor grading and staging was exhibited by TA-MUC1staining, while being negative in normal tissues. Expression of p16 significantly increased in T4 compared to T1 tumors. Significant differences in overall survival were found in correlation to TNM-classification, grading and relapse. TA-MUC1 showed a positive trend correlating to p16. Conclusion: Because of this positive trend, we suggest a HPV association in head and neck tumors. Most likely due to an insufficient quantity of HPV-positive patients, no statistical significance could be established. However, targeting TA-MUC1 would improve tumor therapy by linking hPankoMab-GEXTM to the overexpressed galectin. Systematic analysis of HPV-association should be performed generally in laryngeal cancer to gain further information about the interaction of HPV and malignancies.
Keywords
Subjects
ENT & OtolaryngologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOtolaryngology: Open Access
- SubjectENT & Otolaryngology
- BylineArticles whose byline prints “Irmi Wiest”
- BylineArticles whose byline prints “Christoph Alexiou”
- BylineArticles whose byline prints “Klaus Friese”
- BylineArticles whose byline prints “Doris Mayr”
- BylineArticles whose byline prints “Christoph Freier”
- BylineArticles whose byline prints “Annika Stiasny”
- BylineArticles whose byline prints “Peter Betz”
- BylineArticles whose byline prints “Marina Pöttler”